87
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections

, , , , , , & show all
Pages 5351-5360 | Published online: 08 Oct 2012

References

  • RascalouGPontierDMenuFGourbiereSEmergence and prevalence of human vector-borne diseases in sink vector populationsPloS One20127e3685822629337
  • HotezPJMolyneuxDHFenwickAControl of neglected tropical diseasesN Engl J Med20073571018102717804846
  • GoyaGFFernandez-PachecoRArrueboMCassinelliNIbarraMRBrownian rotational relaxation and power absorption in magnetite nanoparticlesJ Magn Magn Mater2007316132135
  • LacroixLMMalakiRBCarreyJMagnetic hyperthermia in single-domain monodisperse FeCo nanoparticles: evidences for Stoner- Wohlfarth behavior and large lossesJ Appl Phys20091052
  • SantosDMCarneiroMWde MouraTRTowards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11Int J Nanomedicine201272115212722619548
  • Danesh-BahreiniMAShokriJSamieiAKamali-SarvestaniEBarzegar-JalaliMMohammadi-SamaniSNanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c miceInt J Nanomedicine2011683584221589651
  • VyasSPGuptaSOptimizing efficacy of amphotericin B through nanomodificationInt J Nanomedicine2006141743217722276
  • BoscardinSBTorrecilhasACManarinRChagas’ disease: an update on immune mechanisms and therapeutic strategiesJ Cell Mol Med2010141373138420070438
  • Pinto DiasJCThe treatment of Chagas disease (South American trypanosomiasis)Ann Intern Med200614477277416702594
  • FilardiLSBrenerZSusceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas diseaseTrans R Soc Trop Med Hyg1987817557593130683
  • WilkinsonSRKellyJMTrypanocidal drugs: mechanisms, resistance and new targetsExpert Rev Mol Med200911e3119863838
  • PepinJMilordFKhondeANiyonsengaTLokoLMpiaBGambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapyTrans R Soc Trop Med Hyg1994884474527570842
  • GotoHLindosoJACurrent diagnosis and treatment of cutaneous and mucocutaneous leishmaniasisExpert Rev Anti Infect Ther2010841943320377337
  • BermanJDHuman leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 yearsClin Infect Dis1997246847039145744
  • BermanJDUS Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasisClin Infect Dis199928495110391695
  • JordanAWustPFahlingHJohnWHinzAFelixRInductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermiaInt J Hyperthermia20092549951119848612
  • GoyaGFGrazuVIbarraMRMagnetic nanoparticles for cancer therapyCurr Nanosci008;4116
  • LeeJ-HJangJ-TChoiJ-SExchange-coupled magnetic nanoparticles for efficient heat inductionNat Nanotechnol2011641842221706024
  • LevyMWilhelmCSiaugueJMHornerOBacriJCGazeauFMagnetically induced hyperthermia: size-dependent heating power of gamma-Fe(2)O(3) nanoparticlesJ Phys Condens Matter20082020413321694262
  • CominiMMengeUWissingJFloheLTrypanothione synthesis in Crithidia revisitedJ Biol Chem20052806850686015537651
  • VergesMACostoRRocaAGUniform and water stable magnetite nanoparticles with diameters around the monodomain-multidomain limitJ Phys D Appl Phys20084113
  • Gonzalez-FernandezMATorresTEAndres-VergesMMagnetic nanoparticles for power absorption: optimizing size, shape and magnetic propertiesJ Solid State Chem200918227792784
  • GoyaGFHandling the particle size and distribution of Fe3O4 nanoparticles through ball millingSolid State Commun2004130783787
  • HergtRDutzSRoderMEffects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermiaJ Phys Condens Matter20082038521421693832
  • HilgerIFruhaufKAndraWHiergeistRHergtRKaiserWAHeating potential of iron oxides for therapeutic purposes in interventional radiologyAcad Radiol2002919820211918373
  • Pineiro-RedondoYBanobre-LopezMPardinas-BlancoIGoyaGLopez-QuintelaMARivasJThe influence of colloidal parameters on the specific power absorption of PAA-coated magnetite nanoparticlesNanoscale Res Lett2011638321711915
  • GoyaGFMarcos-CamposIFernandez-PachecoRDendritic cell uptake of iron-based magnetic nanoparticlesCell Biol Int2008321001100518534870
  • Marcos-CamposIAsinLTorresTECell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cellsNanotechnology20112220510121444956
  • VillanuevaAde la PresaPAlonsoJMHyperthermia HeLa cell treatment with silica-coated manganese oxide nanoparticlesJ Phys Chem C201011419761981
  • RichardsonHHCarlsonMTTandlerPJHernandezPGovorovAOExperimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutionsNano Lett200991139114619193041
  • SchildkopfPFreyBMantelFApplication of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cellsBiochem Biophys Res Commun20103911014102019968962
  • PeterMEProgrammed cell death: apoptosis meets necrosisNature201147131031221412328
  • CreixellMBohorquezACTorres-LugoMRinaldiCEGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature riseACS Nano201157124712921838221
  • AsínLIbarraMTresAGoyaGFControlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentrationPharm Res20122951319132722362408
  • LunovOZablotskiiVPastorJMThermal destruction on the nanoscale: cell membrane hyperthermia with functionalized magnetic nanoparticlesHafeliUSchuttWZborowskiM8th International Conference on the Scientific and Clinical Applications of Magnetic Carriers1311Melville, NYAmer Inst Physics2010